Data / Form D filings / Ocugen, Inc.
Ocugen, Inc.: Form D filings
Ocugen, Inc., a biotechnology company in Malvern, PA, filed 7 Form D notices with the SEC between 2011 and 2020. The latest, on May 7, 2020, reports $395 sold of a $395 offering to 1 investor.
Find out what Ocugen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5 GREAT VALLEY PARKWAY, SUITE 160, Malvern, PA, 19355
- Phone
- (484) 328-4698
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1372299
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 7, 2020 | New notice | $395 | $395 | $0 | 1 | Apr 22, 2020 | sec.gov |
| May 7, 2020 | New notice | $14,283,724 | $14,283,724 | $0 | 6 | Apr 22, 2020 | sec.gov |
| Oct 12, 2016 | New notice | $30,000,001 | $30,000,001 | $0 | 20 | Sep 29, 2016 | sec.gov |
| Jan 6, 2014 | New notice | $20,647,968 | $10,323,988 | $10,323,980 | 17 | Dec 18, 2013 | sec.gov |
| Nov 26, 2012 | Amendment | $58,286,647 | $37,638,679 | $20,647,968 | 13 | Jul 20, 2012 | sec.gov |
| Jul 27, 2012 | New notice | $58,036,647 | $37,488,679 | $20,547,968 | 12 | Jul 20, 2012 | sec.gov |
| May 26, 2011 | New notice | Indefinite | $34,300,000 | Indefinite | 15 | May 13, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Manish B Potti | Director | |
| Sanjay B Subramanian | Executive Officer | |
| Suha B Taspolatoglu | Director | |
| Shankar Musunuri | Executive Officer, Director | |
| Daniel B Jorgensen | Executive Officer | |
| Prabhavathi B Fernandes | Director | |
| Kristen B Castillo | Director | |
| Ramesh Kumar | Director | |
| Kelly B Beck | Executive Officer | |
| Uday B Kompella | Director | |
| Rasappa B Arumugham | Executive Officer | |
| Vijay B Tammara | Executive Officer | |
| Junge Zhang | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of May 4, 2020 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ocugen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.